Literature DB >> 23738704

CD27+ B cells from a subgroup of common variable immunodeficiency patients are less sensitive to apoptosis rescue regardless of interleukin-21 signalling.

A Clemente1, J Pons, N Lanio, N Matamoros, J M Ferrer.   

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinaemia and recurrent infections. Although the underlying cause is unknown, B cells from most CVID patients fail to differentiate to memory or plasma cells. We investigated if increased apoptosis could influence the fate of B cells. For this purpose we activated purified B lymphocytes of CVID patients with a surrogate T-dependent (anti-CD40) or T-independent [cytosine-phosphate-guanosine oligodeoxynucleotides (CpG-ODN) or anti-immunoglobulin (Ig)M)] stimulus with or without interleukin (IL)-21. We found that CD27(+) B cells were more sensitive than CD27(-) B cells to spontaneous apoptosis and less sensitive to rescue from apoptosis. The addition of IL-21 down-modulated the protective effect of all the stimuli on CD27(-) B cells and the protective effect of CpG-ODN and anti-IgM on CD27(+) B cells. In contrast, IL-21 rescued unstimulated CD27(-) B cells and improved the rescue of anti-CD40-stimulated CD27(+) B cells. When we compared patients and controls, mainly CD27(+) B cells from MB0 patients were less sensitive to rescue from apoptosis than those from MB1 patients and controls after activation, irrespective of the IL-21 effect. Increased apoptosis during an immune response could result in lower levels of immunoglobulin production in these patients.
© 2013 British Society for Immunology.

Entities:  

Keywords:  CD27+ B cells; CVID; IL-21; TRAIL; apoptosis

Mesh:

Substances:

Year:  2013        PMID: 23738704      PMCID: PMC3784217          DOI: 10.1111/cei.12150

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

Review 2.  B lymphocyte activation by contact-mediated interactions with T lymphocytes.

Authors:  G A Bishop; B S Hostager
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

3.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

Authors:  Nadia L Bernasconi; Nobuyuki Onai; Antonio Lanzavecchia
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

4.  T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells.

Authors:  Tatyana Chtanova; Stuart G Tangye; Rebecca Newton; Nita Frank; Martin R Hodge; Michael S Rolph; Charles R Mackay
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

5.  Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help.

Authors:  Magdalena Hagn; Kai Sontheimer; Karen Dahlke; Sabine Brueggemann; Christof Kaltenmeier; Thamara Beyer; Stefanie Hofmann; Oleg Lunov; Thomas F E Barth; Dorit Fabricius; Kyrylo Tron; Gerd Ulrich Nienhaus; Thomas Simmet; Hubert Schrezenmeier; Bernd Jahrsdörfer
Journal:  Immunol Cell Biol       Date:  2011-08-02       Impact factor: 5.126

6.  TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.

Authors:  Josie Ursini-Siegel; Wenli Zhang; Anne Altmeyer; Eunice N Hatada; Richard K G Do; Hideo Yagita; Selina Chen-Kiang
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

7.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

8.  The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.

Authors:  Rita Carsetti; Maria Manuela Rosado; Simona Donnanno; Vanessa Guazzi; Annarosa Soresina; Antonella Meini; Alessandro Plebani; Fernando Aiuti; Isabella Quinti
Journal:  J Allergy Clin Immunol       Date:  2005-02       Impact factor: 10.793

9.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

10.  Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis.

Authors:  Haoli Jin; Roberto Carrio; Aixin Yu; Thomas R Malek
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  7 in total

1.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 2.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

3.  Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.

Authors:  Marylin Desjardins; Marianne Béland; Marieme Dembele; Duncan Lejtenyi; Jean-Phillipe Drolet; Martine Lemire; Christos Tsoukas; Moshe Ben-Shoshan; Francisco J D Noya; Reza Alizadehfar; Christine T McCusker; Bruce D Mazer
Journal:  J Clin Immunol       Date:  2017-11-04       Impact factor: 8.317

4.  IL-21 and anti-CD40 restore Bcl-2 family protein imbalance in vitro in low-survival CD27+ B cells from CVID patients.

Authors:  Antonio López-Gómez; Antonio Clemente; Vanesa Cunill; Jaime Pons; Joana M Ferrer
Journal:  Cell Death Dis       Date:  2018-11-21       Impact factor: 8.469

5.  Defective Bcl-2 expression in memory B cells from common variable immunodeficiency patients.

Authors:  L Del Pino Molina; J M Torres Canizales; O Pernía; R Rodríguez Pena; I Ibanez de Caceres; E López Granados
Journal:  Clin Exp Immunol       Date:  2020-10-08       Impact factor: 5.732

6.  Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients.

Authors:  Ankit Saxena; Hideo Yagita; Thomas W Donner; Abdel Rahim A Hamad
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

7.  TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency.

Authors:  Kristine Lillebø Holm; Randi Gussgard Syljuåsen; Grete Hasvold; Lene Alsøe; Hilde Nilsen; Kristina Ivanauskiene; Philippe Collas; Sergey Shaposhnikov; Andrew Collins; Randi Larsen Indrevær; Pål Aukrust; Børre Fevang; Heidi Kiil Blomhoff
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.